Related Experiment Video

Updated: Aug 8, 2026

Isolation of Functional Cardiac Immune Cells
07:26

Isolation of Functional Cardiac Immune Cells

Published on: December 5, 2011

[Pathophysiological role of cytokines in heart failure]

Takeshi Horio1

  • 1Division of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 13, 2006
PubMed

Insights

Proinflammatory cytokines like tumor necrosis factor-alpha (TNF-alpha) and interleukins are elevated in heart failure, contributing to cardiac remodeling. These cytokines, along with vasoactive peptides, are key players in heart failure development and progression.

Area of Science:

  • Biochemistry
  • Cardiology
  • Immunology

Context:

  • Elevated proinflammatory cytokines (TNF-alpha, IL-1beta, IL-6) in heart failure patients.
  • Stimulation of cytokine production by viral infection, cardiac overload, ischemia, and neuro-humoral factors.
  • Cytokines and vasoactive peptides (endothelin, adrenomedullin) exhibit cytokine-like functions in the heart.

Purpose:

  • To investigate the role of proinflammatory cytokines and vasoactive peptides in heart failure pathogenesis.
  • To elucidate the mechanisms by which these factors contribute to cardiac remodeling.

Summary:

  • Systemic and myocardial levels of proinflammatory cytokines are increased in heart failure.
  • These cytokines directly impair myocardial contractility and induce apoptosis, hypertrophy, and fibrosis.
  • Vasoactive peptides act as autocrine/paracrine factors with cytokine-like effects.

Impact:

  • Proinflammatory cytokines and vasoactive peptides are critical in the pathogenesis and pathophysiology of heart failure.
  • Understanding these roles may lead to novel therapeutic strategies for heart failure.
  • Highlights the complex interplay between inflammation, neuro-humoral factors, and cardiac dysfunction.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...